Literature DB >> 31470035

IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans.

Luana S Ortolan1, Sa Rang Kim2, Sydney Crotts1, Lucy Y Liu2, Brittany G Craiglow3, Carlos Wambier4, Renato S Paschoal5, Brett A King6, Ali Jabbari7.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31470035      PMCID: PMC6900443          DOI: 10.1016/j.jaci.2019.08.014

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  21 in total

1.  Early Th1/Th2 cell polarization in the absence of IL-4 and IL-12: T cell receptor signaling regulates the response to cytokines in CD4 and CD8 T cells.

Authors:  A Noble; M J Thomas; D M Kemeny
Journal:  Eur J Immunol       Date:  2001-07       Impact factor: 5.532

2.  Response to ustekinumab in three pediatric patients with alopecia areata.

Authors:  Abdullah Aleisa; Yeun Lim; Samantha Gordon; Min Ji Her; Pedro Zancanaro; Minawaer Abudu; Sandhya Chowdary Deverapalli; Abdulaziz Madani; David Rosmarin
Journal:  Pediatr Dermatol       Date:  2018-10-18       Impact factor: 1.588

3.  Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.

Authors:  Luzhou Xing; Zhenpeng Dai; Ali Jabbari; Jane E Cerise; Claire A Higgins; Weijuan Gong; Annemieke de Jong; Sivan Harel; Gina M DeStefano; Lisa Rothman; Pallavi Singh; Lynn Petukhova; Julian Mackay-Wiggan; Angela M Christiano; Raphael Clynes
Journal:  Nat Med       Date:  2014-08-17       Impact factor: 53.440

4.  High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of γδ T cells with macrophages.

Authors:  Xuefu Wang; Rui Sun; Haiming Wei; Zhigang Tian
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

5.  Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts.

Authors:  K J McElwee; D Boggess; L E King; J P Sundberg
Journal:  J Invest Dermatol       Date:  1998-11       Impact factor: 8.551

6.  An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis.

Authors:  A Jabbari; F Sansaricq; J Cerise; J C Chen; A Bitterman; G Ulerio; J Borbon; R Clynes; A M Christiano; J Mackay-Wiggan
Journal:  J Invest Dermatol       Date:  2018-02-13       Impact factor: 8.551

7.  Molecular signatures define alopecia areata subtypes and transcriptional biomarkers.

Authors:  Ali Jabbari; Jane E Cerise; James C Chen; Julian Mackay-Wiggan; Madeleine Duvic; Vera Price; Maria Hordinsky; David Norris; Raphael Clynes; Angela M Christiano
Journal:  EBioMedicine       Date:  2016-03-31       Impact factor: 8.143

8.  CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS.

Authors:  Dimitris Skokos; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2007-06-18       Impact factor: 14.307

9.  Parasite-Specific CD4+ IFN-γ+ IL-10+ T Cells Distribute within Both Lymphoid and Nonlymphoid Compartments and Are Controlled Systemically by Interleukin-27 and ICOS during Blood-Stage Malaria Infection.

Authors:  Ana Villegas-Mendez; Tovah N Shaw; Colette A Inkson; Patrick Strangward; J Brian de Souza; Kevin N Couper
Journal:  Infect Immun       Date:  2015-10-12       Impact factor: 3.441

10.  Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata.

Authors:  Amal Elkady; Lauren Bonomo; Yasmin Amir; Anjali S Vekaria; Emma Guttman-Yassky
Journal:  JAAD Case Rep       Date:  2017-09-23
View more
  4 in total

Review 1.  The current state of knowledge of the immune ecosystem in alopecia areata.

Authors:  Samuel J Connell; Ali Jabbari
Journal:  Autoimmun Rev       Date:  2022-02-10       Impact factor: 17.390

Review 2.  Treatment of pediatric alopecia areata: A systematic review.

Authors:  Virginia R Barton; Atrin Toussi; Smita Awasthi; Maija Kiuru
Journal:  J Am Acad Dermatol       Date:  2021-04-30       Impact factor: 15.487

Review 3.  The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside.

Authors:  Taoming Liu; Sheng Li; Shuni Ying; Shunli Tang; Yuwei Ding; Yali Li; Jianjun Qiao; Hong Fang
Journal:  Front Immunol       Date:  2020-11-17       Impact factor: 7.561

Review 4.  From IL-17 to IFN-γ in inflammatory skin disorders: Is transdifferentiation a potential treatment target?

Authors:  Arno Belpaire; Nanja van Geel; Reinhart Speeckaert
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.